Bhart Biotech

As India awaits EUL nod for Covaxin, WHO says ‘decision may take longer time’

WHO Chief Scientist Soumya Swaminathan had said in a tweet earlier that the technical advisory group at WHO will meet on October 26 to consider the Emergency Use Listing for Covaxin being manufactured by India's Bharat Biotech.

Oct 22, 2021, 13:12 PM IST

Bharat Biotech's Covaxin shows 77.8 % efficacy in phase 3 data trial: Sources

The review meeting took place taking before Bharat Biotech`s pre-submission meeting on Wednesday with the World Health Organization (WHO), for the approval for their COVID vaccine `Covaxin`.

Jun 22, 2021, 15:52 PM IST